• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项 1303 例韩国全外显子组测序研究的结果。

Findings of a 1303 Korean whole-exome sequencing study.

机构信息

Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.

Department of Biochemistry and Molecular Biology, Seoul National University College of Medicine, Seoul, Korea.

出版信息

Exp Mol Med. 2017 Jul 14;49(7):e356. doi: 10.1038/emm.2017.142.

DOI:10.1038/emm.2017.142
PMID:28706299
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5565953/
Abstract

Ethnically specific data on genetic variation are crucial for understanding human biology and for clinical interpretation of variant pathogenicity. We analyzed data obtained by deep sequencing 1303 Korean whole exomes; the data were generated by three independent whole exome sequencing projects (named the KOEX study). The primary focus of this study was to comprehensively analyze the variant statistics, investigate secondary findings that may have clinical actionability, and identify loci that should be cautiously interpreted for pathogenicity. A total of 495 729 unique variants were identified at exonic regions, including 169 380 nonsynonymous variants and 4356 frameshift insertion/deletions. Among these, 76 607 were novel coding variants. On average, each individual had 7136 nonsynonymous single-nucleotide variants and 74 frameshift insertion/deletions. We classified 13 pathogenic and 13 likely pathogenic variants in 56 genes that may have clinical actionability according to the guidelines of the American College of Medical Genetics and Genomics, and the Association for Molecular Pathology. The carrier frequency of these 26 variants was 2.46% (95% confidence interval 1.73-3.46). To identify loci that require cautious interpretation in clinical sequencing, we identified 18 genes that are prone to sequencing errors, and 671 genes that are highly polymorphic and carry excess nonsynonymous variants. The catalog of identified variants, its annotation and frequency information are publicly available (http://koex.snu.ac.kr). These findings should be useful resources for investigating ethnically specific characteristics in human health and disease.

摘要

关于遗传变异的种族特异性数据对于理解人类生物学和临床变异致病性的解释至关重要。我们分析了通过对 1303 个韩国人全外显子组进行深度测序获得的数据;这些数据由三个独立的全外显子组测序项目(命名为 KOEX 研究)生成。本研究的主要重点是全面分析变异统计学,调查可能具有临床可操作性的次要发现,并确定应谨慎解释致病性的基因座。在编码区共鉴定出 495729 个独特的变异,包括 169380 个非同义变异和 4356 个移码插入/缺失。其中,76607 个是新的编码变异。平均而言,每个人有 7136 个非同义单核苷酸变异和 74 个移码插入/缺失。根据美国医学遗传学与基因组学学院和分子病理学协会的指南,我们将 56 个可能具有临床可操作性的基因中的 13 个致病性和 13 个可能致病性的变异分类为可能具有临床可操作性,并鉴定出这些 26 个变异的携带频率为 2.46%(95%置信区间为 1.73-3.46)。为了确定在临床测序中需要谨慎解释的基因座,我们鉴定了 18 个易发生测序错误的基因,和 671 个高度多态性且携带过多非同义变异的基因。已鉴定变异的目录及其注释和频率信息可在(http://koex.snu.ac.kr)上公开获取。这些发现应该是研究人类健康和疾病中种族特异性特征的有用资源。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/896e/5565953/f325161b2b15/emm2017142f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/896e/5565953/2c060dd8977b/emm2017142f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/896e/5565953/5bd48dc5ca70/emm2017142f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/896e/5565953/f325161b2b15/emm2017142f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/896e/5565953/2c060dd8977b/emm2017142f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/896e/5565953/5bd48dc5ca70/emm2017142f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/896e/5565953/f325161b2b15/emm2017142f3.jpg

相似文献

1
Findings of a 1303 Korean whole-exome sequencing study.一项 1303 例韩国全外显子组测序研究的结果。
Exp Mol Med. 2017 Jul 14;49(7):e356. doi: 10.1038/emm.2017.142.
2
Whole Exome Sequencing Identifies Novel De Novo Variants Interacting with Six Gene Networks in Autism Spectrum Disorder.全外显子组测序鉴定出与自闭症谱系障碍中六个基因网络相互作用的新型新生变异。
Genes (Basel). 2020 Dec 22;12(1):1. doi: 10.3390/genes12010001.
3
A Screening Approach to Identify Clinically Actionable Variants Causing Congenital Heart Disease in Exome Data.一种在外显子数据中识别导致先天性心脏病的临床可操作变异的筛选方法。
Circ Genom Precis Med. 2018 Mar;11(3):e001978. doi: 10.1161/CIRCGEN.117.001978.
4
Prospective Evaluation of the Utility of Whole Exome Sequencing in Dilated Cardiomyopathy.扩张型心肌病全外显子组测序的效用的前瞻性评估。
J Am Heart Assoc. 2020 Jan 21;9(2):e013346. doi: 10.1161/JAHA.119.013346. Epub 2020 Jan 14.
5
Frequency and spectrum of actionable pathogenic secondary findings in 196 Korean exomes.196 个韩国外显子组中可采取行动的致病性二级发现的频率和频谱。
Genet Med. 2015 Dec;17(12):1007-11. doi: 10.1038/gim.2015.26. Epub 2015 Apr 9.
6
Germline Mutations for Novel Candidate Predisposition Genes in Sporadic Schwannomatosis.散发性许旺细胞瘤中新型候选易感性基因的种系突变。
Clin Orthop Relat Res. 2020 Nov;478(11):2442-2450. doi: 10.1097/CORR.0000000000001239.
7
Korean Variant Archive (KOVA): a reference database of genetic variations in the Korean population.韩国变异体档案(KOVA):韩国人群遗传变异的参考数据库。
Sci Rep. 2017 Jun 27;7(1):4287. doi: 10.1038/s41598-017-04642-4.
8
Whole-exome sequencing identifies MYO15A mutations as a cause of autosomal recessive nonsyndromic hearing loss in Korean families.全外显子组测序发现 MYO15A 突变是导致韩国家族性常染色体隐性非综合征性听力损失的原因。
BMC Med Genet. 2013 Jul 17;14:72. doi: 10.1186/1471-2350-14-72.
9
Nonsynonymous variants in MYH9 and ABCA4 are the most frequent risk loci associated with nonsyndromic orofacial cleft in Taiwanese population.MYH9和ABCA4中的非同义变异是台湾人群中与非综合征性口面部裂隙相关的最常见风险位点。
BMC Med Genet. 2016 Aug 15;17(1):59. doi: 10.1186/s12881-016-0322-2.
10
Assessment of incidental findings in 232 whole-exome sequences from the Baylor-Hopkins Center for Mendelian Genomics.对来自贝勒-霍普金斯孟德尔基因组学中心的232个全外显子组序列中的偶然发现进行评估。
Genet Med. 2015 Oct;17(10):782-8. doi: 10.1038/gim.2014.196. Epub 2015 Jan 8.

引用本文的文献

1
Secondary Findings from Exome Sequencing of a Greek Cohort.希腊队列外显子组测序的次要发现
Curr Issues Mol Biol. 2025 Apr 11;47(4):272. doi: 10.3390/cimb47040272.
2
Medically Actionable Secondary Findings from Whole-Exome Sequencing (WES) Data in a Sample of 3972 Individuals.对3972名个体样本的全外显子组测序(WES)数据进行的具有医学可操作性的次要发现
Int J Mol Sci. 2025 Apr 9;26(8):3509. doi: 10.3390/ijms26083509.
3
Secondary findings in hereditary cancer genes after germline genetic testing - systematic review of literature.生殖系基因检测后遗传性癌症基因的次要发现——文献系统综述

本文引用的文献

1
Analysis of protein-coding genetic variation in 60,706 humans.对60706名人类的蛋白质编码基因变异进行分析。
Nature. 2016 Aug 18;536(7616):285-91. doi: 10.1038/nature19057.
2
The genetic architecture of type 2 diabetes.2型糖尿病的遗传结构
Nature. 2016 Aug 4;536(7614):41-47. doi: 10.1038/nature18642. Epub 2016 Jul 11.
3
Performance of ACMG-AMP Variant-Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research Consortium.临床测序探索性研究联盟中九个实验室对ACMG-AMP变异解读指南的执行情况。
Hum Genet. 2025 Apr 28. doi: 10.1007/s00439-025-02746-w.
4
Central neurocytoma exhibits radial glial cell signatures with FGFR3 hypomethylation and overexpression.中枢神经细胞瘤呈现放射状胶质细胞特征,表现为 FGFR3 低甲基化和过表达。
Exp Mol Med. 2024 Apr;56(4):975-986. doi: 10.1038/s12276-024-01204-3. Epub 2024 Apr 12.
5
Frequency of actionable secondary findings in 7472 Korean genomes derived from the National Project of Bio Big Data pilot study.源自韩国生物大数据国家试点研究的 7472 份韩国家族基因组中可采取行动的二级发现的频率。
Hum Genet. 2023 Nov;142(11):1561-1569. doi: 10.1007/s00439-023-02592-8. Epub 2023 Sep 20.
6
Clinically actionable secondary findings in 130 triads from sub-Saharan African families with non-syndromic orofacial clefts.撒哈拉以南非洲地区非综合征性口腔颌面裂家系中 130 对三体型中的临床可操作性次要发现。
Mol Genet Genomic Med. 2023 Oct;11(10):e2237. doi: 10.1002/mgg3.2237. Epub 2023 Jul 26.
7
Genomic analysis as a tool to infer disparate phylogenetic origins of dysembryoplastic neuroepithelial tumors and their satellite lesions.基因组分析作为推断胚胎发育不良性神经上皮肿瘤及其卫星病变不同进化起源的工具。
Sci Rep. 2023 Jan 13;13(1):682. doi: 10.1038/s41598-022-26636-7.
8
An integrative approach for exploring the nature of fibroepithelial neoplasms.一种探索纤维上皮性肿瘤本质的综合方法。
Br J Cancer. 2023 Feb;128(4):626-637. doi: 10.1038/s41416-022-02064-2. Epub 2022 Dec 16.
9
A retrospective single-centered, comprehensive targeted genetic sequencing analysis of prognostic survival using tissues from Korean patients with metastatic renal cell carcinoma after targeted therapy.回顾性单中心、综合靶向基因测序分析对接受靶向治疗后转移性肾细胞癌韩国患者组织的预后生存影响。
Investig Clin Urol. 2022 Nov;63(6):602-611. doi: 10.4111/icu.20210341.
10
Landscape of Secondary Findings in Chinese Population: A Practice of ACMG SF v3.0 List.中国人群次要发现的概况:ACMG SF v3.0清单的实践
J Pers Med. 2022 Sep 14;12(9):1503. doi: 10.3390/jpm12091503.
Am J Hum Genet. 2016 Jun 2;98(6):1067-1076. doi: 10.1016/j.ajhg.2016.03.024. Epub 2016 May 12.
4
Evaluation of ACMG-Guideline-Based Variant Classification of Cancer Susceptibility and Non-Cancer-Associated Genes in Families Affected by Breast Cancer.基于美国医学遗传学与基因组学学会(ACMG)指南对乳腺癌家族中癌症易感性基因和非癌症相关基因变异分类的评估
Am J Hum Genet. 2016 May 5;98(5):801-817. doi: 10.1016/j.ajhg.2016.02.024.
5
A global reference for human genetic variation.人类遗传变异的全球参考。
Nature. 2015 Oct 1;526(7571):68-74. doi: 10.1038/nature15393.
6
Secondary findings and carrier test frequencies in a large multiethnic sample.一个大型多民族样本中的次要发现和携带者检测频率。
Genome Med. 2015 Jun 13;7(1):54. doi: 10.1186/s13073-015-0171-1. eCollection 2015.
7
Frequency and spectrum of actionable pathogenic secondary findings in 196 Korean exomes.196 个韩国外显子组中可采取行动的致病性二级发现的频率和频谱。
Genet Med. 2015 Dec;17(12):1007-11. doi: 10.1038/gim.2015.26. Epub 2015 Apr 9.
8
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.序列变异解读的标准与指南:美国医学遗传学与基因组学学会和分子病理学协会的联合共识推荐
Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.
9
Second-generation PLINK: rising to the challenge of larger and richer datasets.第二代PLINK:应对更大、更丰富数据集的挑战
Gigascience. 2015 Feb 25;4:7. doi: 10.1186/s13742-015-0047-8. eCollection 2015.
10
Actionable exomic incidental findings in 6503 participants: challenges of variant classification.6503名参与者中可采取行动的外显子组偶然发现:变异分类的挑战
Genome Res. 2015 Mar;25(3):305-15. doi: 10.1101/gr.183483.114. Epub 2015 Jan 30.